Evaluation of the TRPM protein family as potential biomarkers for various types of human cancer using public database analyses
- Authors:
- Fuchuang Qin
- Lingdi Lao
- Minhua Huang
- Hang Tan
- Xuhong Jin
- Xilie Ma
- Jianping Zeng
-
Affiliations: Department of Neurosurgery, Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang 310003, P.R. China, Department of Neurobiology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000, P.R. China, Department of Neurosurgery, Hangzhou Mingzhou Brain Rehabilitation Hospital, Hangzhou, Zhejiang 310012, P.R. China , Department of Osteology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310004, P.R. China , Department of Neurosurgery, The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China - Published online on: May 12, 2020 https://doi.org/10.3892/etm.2020.8739
- Pages: 770-785
-
Copyright: © Qin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
 |
 |
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Fidler MM, Soerjomataram I and Bray F: A global view on cancer incidence and national levels of the human development index. Int J Cancer. 139:2436–2446. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Montell C and Rubin GM: Molecular characterization of the Drosophila trp locus: A putative integral membrane protein required for phototransduction. Neuron. 2:1313–1323. 1989.PubMed/NCBI View Article : Google Scholar | |
|
Schmitz C and Perraud AL: The TRPM cation channels in the immune context. Curr Pharm Design. 11:2765–2778. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Zeng X, Sikka SC, Huang L, Sun C, Xu C, Jia D, Abdel-Mageed AB, Pottle JE, Taylor JT and Li M: Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation. Prostate Cancer Prostatic Dis. 13:195–201. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Armisen R, Marcelain K, Simon F, Tapia JC, Toro J, Quest AF and Stutzin A: TRPM4 enhances cell proliferation through up-regulation of the β-catenin signaling pathway. J Cell Physiol. 226:103–109. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Meng X, Cai C, Wu J, Cai S, Ye C, Chen H, Yang Z, Zeng H, Shen Q and Zou F: TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway. Cancer Lett. 333:96–102. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Hantute-Ghesquier A, Haustrate A, Prevarskaya N and Lehen'kyi V: TRPM family channels in cancer. Pharmaceuticals (Basel). 11(2)2018.PubMed/NCBI View Article : Google Scholar | |
|
Wong KK, Banham AH, Yaacob NS and Nur Husna SM: The oncogenic roles of TRPM ion channels in cancer. J Cell Physiol, 2019. | |
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy B: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 8(9227)2018.PubMed/NCBI View Article : Google Scholar | |
|
Li Q, Birkbak NJ, Gyorffy B, Szallasi Z and Eklund AC: Jetset: Selecting an optimal microarray probe set to represent a gene. BMC Bioinformatics. 12(474)2011.PubMed/NCBI View Article : Google Scholar | |
|
Mizuno H, Kitada K, Nakai K and Sarai A: PrognoScan: A new database for meta-analysis of the prognostic value of genes. BMC Med Genomics. 2(18)2009.PubMed/NCBI View Article : Google Scholar | |
|
Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z: GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q and Szallasi Z: An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 123:725–731. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA. 98:13790–13795. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, et al: Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA. 98:13784–13789. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S, et al: Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res. 72:100–111. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Gyorffy B, Surowiak P, Budczies J and Lanczky A: Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 8(e82241)2013.PubMed/NCBI View Article : Google Scholar | |
|
Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D, Pachlewski J, Oledzki J and Ostrowski J: Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One. 5(pii: e13091)2010.PubMed/NCBI View Article : Google Scholar | |
|
Hong Y, Downey T, Eu KW, Koh PK and Cheah PY: A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis. 27:83–90. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, Rehrauer H, Laczko E, Kurowski MA, Bujnicki JM, Menigatti M, et al: Transcriptome profile of human colorectal adenomas. Mol Cancer Res. 5:1263–1275. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D, Pachlewski J, Oledzki J and Ostrowski J: Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One. 5(pii: e13091)2010.PubMed/NCBI View Article : Google Scholar | |
|
Gaedcke J, Grade M, Jung K, Camps J, Jo P, Emons G, Gehoff A, Sax U, Schirmer M, Becker H, et al: Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase and SMYD3, a histone methyltransferase, in rectal carcinomas. Genes Chromosomes Cancer. 49:1024–1034. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, et al: Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 8(R131)2007.PubMed/NCBI View Article : Google Scholar | |
|
D'Errico M, de Rinaldis E, Blasi MF, Viti V, Falchetti M, Calcagnile A, Sera F, Saieva C, Ottini L, Palli D, et al: Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer. 45:461–469. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Wang Q, Wen YG, Li DP, Xia J, Zhou CZ, Yan DW, Tang HM and Peng ZH: Upregulated INHBA expression is associated with poor survival in gastric cancer. Med Oncol. 29:77–83. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, et al: Integrative molecular concept modeling of prostate cancer progression. Nat Genet. 39:41–51. 2007.PubMed/NCBI View Article : Google Scholar | |
|
VVarambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, et al: Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell. 8:393–406. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, Dalton WB, Williams H, Karanam S, Datta MW, Jaye DL, et al: Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res. 66:4011–4019. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Vanaja DK, Cheville JC, Iturria SJ and Young CYF: Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Res. 63:3877–3882. 2003.PubMed/NCBI | |
|
Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, et al: The mutational landscape of lethal castration-resistant prostate cancer. Nature. 487:239–243. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Arredouani MS, Lu B, Bhasin M, Eljanne M, Yue W, Mosquera JM, Bubley GJ, Li V, Rubin MA, Libermann TA, et al: Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer. Clin Cancer Res. 15:5794–5802. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Wallace TA, Prueitt RL, Yi M, Howe TM, Gillespie JW, Yfantis HG, Stephens RM, Caporaso NE, Loffredo CA and Ambs S: Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res. 68:927–936. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, Atkins D and Wang Y: Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res. 11:7234–7242. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam BL, Federman S, Miller JR III, Allen RE, Singer MI, et al: The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA. 102:6092–6097. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, et al: The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics. 1(13)2008.PubMed/NCBI View Article : Google Scholar | |
|
Cutcliffe C, Kersey D, Huang CC, Zeng Y, Walterhouse D and Perlman EJ: Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin Cancer Res. 11:7986–7994. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Jones J1, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, et al: Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res. 11:5730–5739. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Gumz ML1, Zou H, Kreinest PA, Childs AC, Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS, et al: Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res. 13:4740–4749. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Beroukhim R1, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA, et al: Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res. 69:4674–4681. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT and Christman MF: Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer. 3(31)2003.PubMed/NCBI View Article : Google Scholar | |
|
Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG and Kovacs G: High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer. 9(152)2009.PubMed/NCBI View Article : Google Scholar | |
|
Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB and Lowe AW: Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology. 131:925–933. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Kimchi ET, Posner MC, Park JO, Darga TE, Kocherginsky M, Karrison T, Hart J, Smith KD, Mezhir JJ, Weichselbaum RR, et al: Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res. 65:3146–3154. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Kim SM, Park YY, Park ES, Cho JY, Izzo JG, Zhang D, Kim SB, Lee JH, Bhutani MS, Swisher SG, Wu X, Coombes KR, et al: Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS One. 5(e15074)2010.PubMed/NCBI View Article : Google Scholar | |
|
Liang Y, Diehn M, Watson N, et al: Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A. 102:5814–5819. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Bredel M1, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD and Sikic BI: Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res. 65:8679–8689. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, et al: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 9:391–403. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Sun L1, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, et al: Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell. 9:287–300. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven MC, et al: Stem cell-related ‘self-renewal’ signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol. 26:3015–3024. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE, Ondrey FG, Adams GL and Gaffney PM: Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res. 64:55–63. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Maule M and Merletti F: Cancer transition and priorities for cancer control. Lancet Oncol. 13:745–746. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Bray F, Soerjomataram I, Mery L and Ferlay J: Improving the quality and coverage of cancer registries globally. Lancet. 386:1035–1036. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Chen J, Luan Y, Yu R, Zhang Z, Zhang J and Wang W: Transient receptor potential (TRP) channels, promising potential diagnostic and therapeutic tools for cancer. Biosci Trends. 8:1–10. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Clapham DE: TRP channels as cellular sensors. Nature. 426:517–524. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Pedersen SF, Owsianik G and Nilius B: TRP channels: An overview. Cell Calcium. 38:233–252. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Gkika D and Prevarskaya N: Molecular mechanisms of TRP regulation in tumor growth and metastasis. Biochim Biophys Acta. 1793:953–958. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Winters S, Martin C, Murphy D and Shokar NK: Breast cancer epidemiology, prevention and screening. Prog Mol Biol Transl. 151:1–32. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Dai X, Xiang L, Li T and Bai Z: Cancer hallmarks, biomarkers and breast cancer molecular subtypes. J Cancer. 7:1281–1294. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J and Shi B: Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res. 5:2929–2943. 2015.PubMed/NCBI | |
|
Spitale A, Mazzola P, Soldini D, Mazzucchelli L and Bordoni A: Breast cancer classification according to immunohistochemical markers: Clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol. 20:628–635. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Sumoza-Toledo A, Espinoza-Gabriel MI and Montiel-Condado D: Evaluation of the TRPM2 channel as a biomarker in breast cancer using public databases analysis. Bol Med Hosp Infant Mex. 73:397–404. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, et al: The landscape of cancer genes and mutational processes in breast cancer. Nature. 486:400–404. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2017. CA Cancer J Clin. 67:7–30. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Huang C, Qin Y, Liu H, Liang N, Chen Y, Ma D, Han Z, Xu X, Zhou X, He J and Li S: Downregulation of a novel long noncoding RNA TRPM2-AS promotes apoptosis in non-small cell lung cancer. Tumour Biol. 39(1010428317691191)2017.PubMed/NCBI View Article : Google Scholar | |
|
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global patterns and trends in colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Bray F, Ren JS, Masuyer E and Ferlay J: Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 132:1133–1145. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Kim BJ, Kim SY, Lee S, Jeon JH, Matsui H, Kwon YK, Kim SJ and So I: The role of transient receptor potential channel blockers in human gastric cancer cell viability. Can J Physiol Pharmacol. 90:175–186. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Almasi S, Kennedy BE, El-Aghil M, Sterea AM, Gujar S, Partida-Sánchez S and El Hiani Y: TRPM2 channel-mediated regulation of autophagy maintains mitochondrial function and promotes gastric cancer cell survival via the JNK-signaling pathway. J Biol Chem. 293:3637–3650. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Bidaux G, Borowiec AS, Dubois C, Delcourt P, Schulz C, Vanden Abeele F, Lepage G, Desruelles E, Bokhobza A, Dewailly E, et al: Targeting of short TRPM8 isoforms induces 4TM-TRPM8-dependent apoptosis in prostate cancer cells. Oncotarget. 7:29063–29080. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Peng M, Wang Z, Yang Z, Tao L, Liu Q, Yi LU and Wang X: Overexpression of short TRPM8 variant a promotes cell migration and invasion and decreases starvation-induced apoptosis in prostate cancer LNCaP cells. Oncol Lett. 10:1378–1384. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Deeds J, Cronin F and Duncan LM: Patterns of melastatin mRNA expression in melanocytic tumors. Hum Pathol. 31:1346–1356. 2000.PubMed/NCBI |
